Dual-Inhibitor Discovery for Diabetes
Applied ML-based QSAR modeling and molecular docking to discover novel dual-inhibitors against SGLT1 and SGLT2 for Type 2 Diabetes treatment.
View Project Details
Applied Machine Learning-based QSAR modeling and molecular docking techniques to discover novel dual-inhibitors against Sodium-Glucose Co-Transporters (SGLT1 and SGLT2) for Diabetes Mellitus Type 2, integrating descriptor analysis, activity prediction, and virtual screening using Python and Machine Learning technologies.